Teladoc Health, Inc. TDOC
6.09
(0.05)
(0.81%)
as of 25 Sep
- Market cap
- $1.1B
- P/E
- 0.0×
Follow TDOC
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(15.42%) | (13.93%) | (12.39%) | (12.99%) | |
| (6.98%) | (6.28%) | (5.48%) | (6.28%) | ||
ROIC |
(10.36%) | (10.27%) | (8.07%) | (7.62%) | |
Return on Tangible Assets |
(31.29%) | (27.02%) | (22.71%) | 85.01% | |
Average Days of Receivables |
30.43 | 27.82 | 31.01 | 32.40 | |
Free Cash Flow per Share |
0.61 | 0.78 | 0.87 | 0.49 | |
Free Cash Flow |
108.31 | 137.33 | 156.26 | 88.56 | |
Capital Expenditures |
(184.20) | (157.02) | (131.69) | (172.62) | |
Piotroski F-Score |
6.00 | 6.00 | 6.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
9.40% | 9.31% | 9.34% | 8.48% | |
Accounts Receivable Turnover |
11.96 | 12.43 | 11.26 | 11.15 | |
Accounts Payable Turnover |
16.97 | 19.03 | 15.88 | 16.81 | |
Inventory Turnover |
19.86 | 20.21 | 22.20 | 23.07 | |
Average Days of Payables |
24.95 | 22.69 | 21.36 | 17.71 | |
Days of Inventory on Hand |
19.08 | 18.07 | 14.91 | 13.62 | |
Tax Rate |
(0.11) | (0.15) | (0.08) | (0.03) | |
Research and Development Expense of Revenue |
11.20% | 10.99% | 10.97% | 10.84% | |
Selling, General and Administrative Expense of Revenue |
51.48% | 50.58% | 49.91% | 49.26% | |
Share Based Compensation of Revenue |
3.64% | 3.18% | 2.78% | 2.28% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(1.31) | (1.47) | (1.68) | (1.47) | |
Depreciation/Fixed assets |
16.37 | 16.62 | 14.96 | 15.82 | |
Capex/Depreciation |
(0.42) | (0.35) | (0.33) | (0.44) | |
Revenue per Share |
14.29 | 14.36 | 14.04 | 13.75 | |
Operating CF per Share |
1.65 | 1.67 | 1.61 | 1.44 | |
Capex per Share |
(1.04) | (0.89) | (0.74) | (0.95) | |
Capex to Sales |
0.07 | 0.06 | 0.05 | 0.07 | |
Net Profit Margin |
(8.84%) | (7.92%) | (6.81%) | (7.13%) |
Columns are period end dates